KLEXALPA Trademark

Trademark Overview

On Tuesday, January 13, 2015, a trademark application was filed for KLEXALPA with the United States Patent and Trademark Office. The USPTO has given the KLEXALPA trademark a serial number of 86501755. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 16, 2024. This trademark is owned by Glaxo Group Limited. The KLEXALPA trademark is filed in the Pharmaceutical Products category with the following description:

(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
klexalpa

General Information

Serial Number86501755
Word MarkKLEXALPA
Filing DateTuesday, January 13, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 16, 2024
Registration Number5253518
Registration DateTuesday, August 1, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 29, 2015

Trademark Statements

Goods and Services(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 16, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford , Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford , Middlesex TW89GS

Trademark Events

Event DateEvent Description
Friday, February 16, 2024CANCELLED SEC. 8 (6-YR)
Tuesday, November 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, August 1, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 1, 2017REGISTERED-PRINCIPAL REGISTER
Monday, June 26, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, May 23, 2017NOTICE OF ALLOWANCE CANCELLED
Wednesday, June 14, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 23, 2017TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, November 8, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, November 5, 2016SOU EXTENSION 2 GRANTED
Thursday, October 13, 2016SOU EXTENSION 2 FILED
Thursday, October 13, 2016SOU TEAS EXTENSION RECEIVED
Friday, May 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 19, 2016SOU EXTENSION 1 GRANTED
Thursday, April 14, 2016SOU EXTENSION 1 FILED
Tuesday, May 17, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 14, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, November 24, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 29, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 29, 2015PUBLISHED FOR OPPOSITION
Wednesday, September 9, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 25, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, August 20, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 19, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 19, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 12, 2015ASSIGNED TO LIE
Wednesday, July 29, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 17, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, April 17, 2015LETTER OF SUSPENSION E-MAILED
Friday, April 17, 2015SUSPENSION LETTER WRITTEN
Friday, April 17, 2015ASSIGNED TO EXAMINER
Friday, January 23, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 16, 2015NEW APPLICATION ENTERED

Related Keywords

klexalpa treatment substances disorders preparations pharmaceutical diseases hepatological respiratory ophthalmic oncological